Testicular cancer: When less is more

Lance C. Pagliaro

doi:10.1007/s11912-010-0105-4

Testicular cancer: When less is more

Lance C. Pagliaro

Medical Oncology

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Clinical stage I testicular cancer is highly curable. The treatment options include adjuvant chemotherapy or surveillance for most patients, radiotherapy for seminoma, and retroperitoneal lymph node dissection for selected patients with nonseminomatous germ cell tumors. This review discusses the decision points with emphasis on the advantages and disadvantages of each management option.

Original language	English (US)
Pages (from-to)	271-277
Number of pages	7
Journal	Current oncology reports
Volume	12
Issue number	4
DOIs	https://doi.org/10.1007/s11912-010-0105-4
State	Published - Jul 2010

Keywords

Carboplatin
Cisplatin
Embryonal carcinoma
Male infertility
Orchiectomy
Radiotherapy
Seminoma
Teratoma
Testicular neoplasm
Treatment-related malignancy

ASJC Scopus subject areas

Oncology

Access to Document

10.1007/s11912-010-0105-4

Cite this

@article{29dcc1f5d8204fe7bc814508707d85ee,

title = "Testicular cancer: When less is more",

abstract = "Clinical stage I testicular cancer is highly curable. The treatment options include adjuvant chemotherapy or surveillance for most patients, radiotherapy for seminoma, and retroperitoneal lymph node dissection for selected patients with nonseminomatous germ cell tumors. This review discusses the decision points with emphasis on the advantages and disadvantages of each management option.",

keywords = "Carboplatin, Cisplatin, Embryonal carcinoma, Male infertility, Orchiectomy, Radiotherapy, Seminoma, Teratoma, Testicular neoplasm, Treatment-related malignancy",

author = "Pagliaro, {Lance C.}",

year = "2010",

month = jul,

doi = "10.1007/s11912-010-0105-4",

language = "English (US)",

volume = "12",

pages = "271--277",

journal = "Current oncology reports",

issn = "1523-3790",

publisher = "Current Science, Inc.",

number = "4",

}

TY - JOUR

T1 - Testicular cancer

T2 - When less is more

AU - Pagliaro, Lance C.

PY - 2010/7

Y1 - 2010/7

N2 - Clinical stage I testicular cancer is highly curable. The treatment options include adjuvant chemotherapy or surveillance for most patients, radiotherapy for seminoma, and retroperitoneal lymph node dissection for selected patients with nonseminomatous germ cell tumors. This review discusses the decision points with emphasis on the advantages and disadvantages of each management option.

AB - Clinical stage I testicular cancer is highly curable. The treatment options include adjuvant chemotherapy or surveillance for most patients, radiotherapy for seminoma, and retroperitoneal lymph node dissection for selected patients with nonseminomatous germ cell tumors. This review discusses the decision points with emphasis on the advantages and disadvantages of each management option.

KW - Carboplatin

KW - Cisplatin

KW - Embryonal carcinoma

KW - Male infertility

KW - Orchiectomy

KW - Radiotherapy

KW - Seminoma

KW - Teratoma

KW - Testicular neoplasm

KW - Treatment-related malignancy

UR - http://www.scopus.com/inward/record.url?scp=77956445326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956445326&partnerID=8YFLogxK

U2 - 10.1007/s11912-010-0105-4

DO - 10.1007/s11912-010-0105-4

M3 - Review article

C2 - 20443156

AN - SCOPUS:77956445326

SN - 1523-3790

VL - 12

SP - 271

EP - 277

JO - Current oncology reports

JF - Current oncology reports

IS - 4

ER -

Testicular cancer: When less is more

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this